The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Colombia, Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.
Biosimilars Latam – Colombia 2020 Forum is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.
Join us in Colombia and trigger a quantum leap in Latin American Healthcare!

Who will
you meet?


More than:









Service Providers

Government Agencies

Industry Executives from Latam

From these areas:
  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance
  • Research
  • Regulatory
  • Business Development
  • Marketing


Latam Biosimilars’s Insight. Panel Industry Leaders

Edgar Mauricio Rubio
Indukern, Colombia
Pharmaceutical & Animal Health Division Manager

Eduardo Cioppi
mAbxience, Argentina
Regional Director – Latin America

Jaime Uribe

Perception on Biosimilars from Local Patients and HCPs. Panel
Nancy Huertas Keralty, Colombia Global Director of Pharmaceutical Affairs Jorge García BIOREDCOL, Colombia President
Pharmacovigilance in Latam
Claudia Patricia Vaca Think Tank “Medicines, Information and Power” UNAL, Colombia Founder and Head
Current Technology used in Latam for Biosimilars Development. Panel
Claudia Marcela Betancour Biointropic, Colombia Executive Director Oscar Gamiz Vargas BD, Mexico Marketing Head PS Latam
International Standard for the Evaluation and Approval of Biologics/Biosimilars. Panel
Carolina Gomez Think Tank “Medicines, Information and Power” UNAL, Colombia Founder and Researcher Jose Josan Universidad Peruana Cayetano Heredia, Peru Professor
What the Future of Biosimilars in Colombia is? Panel
Nidia Delgado National Cancer Institute, Colombia Instructor
Full programme in the PDF Agenda



The production of biologic-based pharmaceuticals is long and complex. Rapid answers from in-process controls confirm your production process is operating as designed—efficiently confirming product quality. With the most comprehensive portfolio of microbiology solutions for bioproduction, bioMérieux helps protect your customers, keep you in compliance, and improve your bottom line.

Becton Dickinson and Company

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories.


We develop alliances with pharmaceutical companies, using Terumo technology to develop, manufacture and supply solutions to injectable drug delivery challenges. We pride ourselves on offering a portfolio of products and services for the pharmaceutical industry. By anticipating trends and maintaining a constant dialogue, we provide a first class customer experience.


Photo Gallery from Previous Events


Keep me updated